Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-27

Clinical Trial Update: To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a single injection of Org 36286 (brand name Ensure; MK-8962-001) for ovarian stimulation in infertility, using daily recombinant FSH as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ensure (Org 36286)

Snippet

Sponsor: Organon and Co | Conditions: Infertility | Phase 3 | Status: COMPLETED | Results posted: 2015-04-27